News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Earnings
BioTime (BTX) To Announce Fourth Quarter And Fiscal 2016 Results On March 16, 2017 2/23/2017
SAGE Therapeutics (SAGE) Announces Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update 2/23/2017
Teleflex Inc. (TFX) Reports Fourth Quarter And Full Year 2016 Results; Provides 2017 Guidance 2/23/2017
Sartorius Reviews Fiscal 2016 2/23/2017
NovoCure Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Company Update 2/23/2017
Ipsen (IPN.PA) Delivers Strong 2016 Results And Expects Further Sales Growth And Margin Enhancement For 2017 2/23/2017
Juno (JUNO) To Report Full Year And Fourth Quarter 2016 Financial Results On Wednesday, March 1 2/23/2017
Clovis Oncology (CLVS) Announces 2016 Operating Results 2/23/2017
bluebird bio (BLUE) Reports Fourth Quarter And Full Year 2016 Financial Results And Recent Operational Progress 2/23/2017
Foundation Medicine, Inc. (FMI) Announces 2016 Fourth Quarter And Year-End Results, Recent Highlights And 2017 Outlook 2/23/2017
Recipharm AB Release: Full Year Report January - December 2016 2/23/2017
TherapeuticsMD (TXMD) Announces Fourth Quarter And Full-Year 2016 Financial Results 2/23/2017
Bluechiip Ltd Half Yearly Report And Accounts 2/23/2017
OncoGenex (OGXI) Reports Financial Results For Year End 2016 2/23/2017
Chimerix (CMRX) To Announce Fourth Quarter And Full Year 2016 Financial Results On March 2, 2017 2/23/2017
Aclaris (ACRS) To Announce Fourth Quarter And Full Year 2016 Financial Results On March 15, 2017 2/23/2017
Intercept Pharma (ICPT) Reports Full Year 2016 Financial Results And Provides Business Update 2/23/2017
Edge Therapeutics Announces Conference Call On March 2, 2017 To Discuss Fourth Quarter And Full Year 2016 Financial Results 2/23/2017
Dermira (DERM) To Report Fourth Quarter And Full Year 2016 Financial Results 2/23/2017
ADM Tronics (ADMT) CEO Comments on December 31, 2016 Third Quarter Financial Results 2/23/2017
Merrimack (MACK) Announces Timing Of Fourth Quarter 2016 Investor Conference Call 2/23/2017
Lannett (LCI) Announces Addition To Management Team 2/23/2017
Aratana Therapeutics (PETX) To Report Fourth Quarter And Full Year 2016 Financial Results 2/23/2017
IRIDEX (IRIX) To Report Fourth Quarter And 2016 Financial Results On March 8, 2017 2/23/2017
Nektar Therapeutics (NKTR) To Announce Financial Results For The Fourth Quarter And Year-Ended 2016 On Wednesday, March 1, 2017, After Close Of U.S.-Based Financial Markets 2/23/2017
CTI BioPharma To Report Fourth Quarter And Full Year 2016 Financial Results On March 2, 2017 2/23/2017
MiMedx Announces 2016 Record Results 2/23/2017
OncoGenex (OGXI) Reports Financial Results For Year End 2016 2/23/2017
PRA Health Sciences Reports Fourth Quarter And Full Year 2016 Results And Provides Q1 And Full Year 2017 Guidance 2/23/2017
Genmab A/S (GEN.CO) 2016 Annual Report 2/23/2017
Cleveland Biolabs Inc. (CBLI) Reports 2016 Financial Results And Development Progress 2/23/2017
CRH Medical Announces 2016 Fourth Quarter And Year-End Results 2/23/2017
Anatara Lifesciences Half Yearly Report And Accounts 2/23/2017
Ophthotech (OPHT) To Report Fourth Quarter And Full Year 2016 Financial Results And Host Conference Call On Tuesday, February 28, 2017 2/22/2017
Acceleron Pharma To Webcast Conference Call Of Fourth Quarter And Year Ended 2016 Financial Results On March 1, 2017 2/22/2017
Ironwood (IRWD) Provides Fourth Quarter And Full Year 2016 Investor Update 2/22/2017
Karolinska Development AB - Q4 And 2016 Year-End Report - Invitation To Conference Call And Webcast 2/22/2017
Nordic Nanovector: Invitation To Fourth Quarter And Full Year 2016 Results Presentation And Webcast 2/22/2017
Esperion (ESPR) Provides Bempedoic Acid Development Program Update; Reports Fourth Quarter And Full Year 2016 Financial Results 2/22/2017
Sangamo Therapeutics (SGMO) Announces Fourth Quarter And Full Year 2016 Conference Call And Webcast 2/22/2017
Synthetic Biologics (SYN) To Report 2016 Year End Operational Highlights And Financial Results On March 2, 2017 2/22/2017
Innophos Holdings, Inc. Reports Fourth Quarter And Full Year 2016 Results 2/22/2017
Wright Medical Group (WMGI) Reports 2016 Fourth Quarter And Full-Year Financial Results And Provides 2017 Guidance 2/22/2017
SQI Diagnostics Reports First Quarter 2017 Results 2/22/2017
MRI Interventions (MRIC) Fourth Quarter And Full Year 2016 Financial Results Conference Call And Webcast 2/22/2017
Geron (GERN) Announces Conference Call To Discuss Fourth Quarter And Annual 2016 Financial Results 2/22/2017
Paratek Pharma (PRTK) To Report Fourth Quarter And Full Year 2016 Financial Results On March 2, 2017 2/22/2017
United Therapeutics (UTHR) Reports 2016 Fourth Quarter And Annual Financial Results 2/22/2017
PDL BioPharma (PDLI) To Announce Fourth Quarter / Year-End 2016 Financial Results On March 1, 2017 2/22/2017
Repligen (RGEN) Reports Fourth Quarter 2016 Financial Results, Provides Guidance For 2017 2/22/2017
Xencor To Host Fourth Quarter And Full Year 2016 Financial Results Webcast And Conference Call On February 28, 2017 2/22/2017
Foamix Pharma (FOMX) Reports Year End 2016 Financial Results And Provides Business Update 2/22/2017
Intrexon (XON) To Announce Fourth Quarter And Full Year 2016 Financial Results On March 1st 2/22/2017
Exactech (EXAC) 2016 Revenue Up 7% To $257.6 Million, Q4’16 Revenue Increased 6% To $66.2 Million 2/21/2017
BioTime (BTX) Reports Pro Forma Gain On Deconsolidation Of OncoCyte Subsidiary 2/21/2017
Baxter International (BAX) Declares Quarterly Dividend 2/21/2017
Confident Medtronic (MDT)'s Q3 Beats Expectations 2/21/2017
Acadia (ACAD) To Announce Fourth Quarter And Full Year 2016 Financial Results On February 28, 2017 2/21/2017
Novavax (NVAX) To Host Conference Call To Discuss Fourth Quarter And Year-End 2016 Financial Results On February 27, 2017 2/21/2017
NeuroVive (NVP) Year End Report January - December 2016 2/21/2017
EXACT Sciences (EXAS) Generated $99.4 Million In Revenues During 2016, A 152-Percent Increase 2/21/2017
SciClone (SCLN) To Report Fourth Quarter And Full Year 2016 Financial Results On March 6, 2017 2/21/2017
Bruker Corporation Announces Quarterly Dividend 2/21/2017
Henry Schein (HSIC) Reports Record Fourth Quarter And Full Year 2016 Financial Results 2/21/2017
AMRI (AMRI) Announces Fourth Quarter And Full Year 2016 Results And Provides 2017 Outlook 2/21/2017
Quest Diagnostics (DGX) Declares Quarterly Cash Dividend 2/21/2017
Biocept, Inc. (BIOC) To Release 2016 Fourth Quarter And Full Year Financial Results And Host Investor Conference Call On March 7, 2017 2/21/2017
Portola (PTLA) To Announce Fourth Quarter And Year-End 2016 Financial Results And Host Conference Call On Tuesday, February 28 2/21/2017
Momenta (MNTA) Reports Fourth Quarter And Year End 2016 Financial Results 2/21/2017
Kindred Bio (KIN) To Announce Fourth Quarter And Year-End 2016 Financial Results 2/21/2017
Vernalis PLC (VNLPY.PK): Unaudited Interim Results For The Six Months Ended 31 December 2016 2/21/2017
Perrigo (PRGO) Announces Quarterly Dividend 2/21/2017
AbbVie (ABBV) Declares Quarterly Dividend 2/20/2017
Ardelyx (ARDX) Reports Clinical Progress And Fourth Quarter And Full Year 2016 Financial Results 2/20/2017
NewLink Genetics (NLNK) To Host Its Fourth Quarter And Year End 2016 Financial Results Conference Call On February 28, 2017 2/20/2017
Momenta (MNTA) Announces Time Change For Fourth Quarter And Year End 2016 Financial Results Conference Call And Webcast 2/20/2017
Invitation To Presentation Of Recipharm AB’s Full Year Report For 2016 On The 23rd February 2/20/2017
The Medicines Company (MDCO) To Announce Fourth-Quarter And Full-Year 2016 Financial Results On February 28, 2017 2/17/2017
ImmunoGen (IMGN) Reports Recent Progress And Operating Results For Six-Month Period And Quarter Ended December 31, 2016 2/17/2017
IntriCon (IIN) Reports 2016 Fourth-Quarter Results 2/17/2017
Revance (RVNC) To Release Fourth Quarter 2016 Financial Results Monday, February 27, 2017 2/17/2017
SAGE Therapeutics (SAGE) To Report Fourth Quarter And Full Year 2016 Financial Results On Thursday, February 23, 2017 2/17/2017
OncoGenex (OGXI) To Report Year End 2016 Financial Results On Feb. 23, 2017 2/17/2017
Cytokinetics (CYTK) Reports Fourth Quarter 2016 Financial Results 2/17/2017
MacroGenics (MGNX) Announces Date Of Fourth Quarter And Full Year 2016 Financial Results Conference Call 2/17/2017
Pain Therapeutics (PTIE) Reports 2016 Financial Results 2/17/2017
Intercept Pharma (ICPT) To Report 2016 Full Year Financial Results On February 23 And Present At Upcoming Conferences 2/17/2017
Repligen To Report Fourth Quarter And Full Year 2016 Financial Results, Provides Financial Guidance For 2017 2/17/2017
OncoGenex (OGXI) To Report Year End 2016 Financial Results On Feb. 23, 2017 2/17/2017
Notice Of Cipher Pharma (DND.TO) Q4 And Year-End 2016 Conference Call 2/17/2017
MiMedx Announces Release Date For 2016 Full Year Results 2/17/2017
China Cord Blood To Report Third Quarter And First Nine Months Fiscal 2017 Financial Results 2/17/2017
Abbott (ABT) Declares 373rd Consecutive Quarterly Dividend 2/17/2017
LabCorp (LH) Announces Record 2016 Fourth Quarter And Full Year Results And Provides 2017 Guidance 2/16/2017
Alexion (ALXN) Stops Work on Early-Stage Sanfilippo B Drug, Takes a $85 Million Write Off 2/16/2017
Zoetis (ZTS) Reports Fourth Quarter And Full Year 2016 Results 2/16/2017
ICON Reports Fourth Quarter And Full Year 2016 Results 2/16/2017
Teva (TEVA) Has Really Bottomed Out This Time 2/16/2017
ConforMIS Reports Fourth Quarter And The Year Ended 2016 Financial Results; Provides 2017 Financial Guidance 2/16/2017
Insmed (INSM) To Host Fourth Quarter And Year-End 2016 Financial Results Conference Call On Thursday, February 23, 2017 2/16/2017
Keryx (KERX) To Host Conference Call Of Fourth Quarter And Full Year 2016 Financial Results On Wednesday, March 1, 2017 2/16/2017
Agios (AGIO) Reports Fourth Quarter And Full Year 2016 Financial Results And Highlights Key 2017 Milestones 2/16/2017
Syndax To Announce Fourth Quarter And Year-End 2016 Financial Results And Host Conference Call And Webcast On March 2, 2017 2/16/2017
Retrophin (RTRX) To Report Fourth Quarter And Full Year 2016 Financial Results 2/16/2017
Vanda (VNDA) Reports Fourth Quarter 2016 And Full Year 2016 Financial Results 2/16/2017
Omega Protein Corporation (OME) Announces Fourth Quarter And Full Year 2016 Earnings Release And Conference Call Dates 2/16/2017
CryoLife (CRY) Reports Fourth Quarter and Full Year 2016 Financial Results 2/16/2017
West Pharmaceutical Services Announces Fourth-Quarter And Full-Year 2016 Results And Announces Quarterly Dividend 2/16/2017
Eagle Pharma (EGRX) To Discuss Fourth Quarter And Full Year 2016 Financial Results On March 1, 2017 2/16/2017
NanoViricides, Inc. (NNVC.PK) Files Quarterly Report For Period Ending 2016-12-31 2/16/2017
STAAR Surgical (STAA) To Report Fourth Quarter Results On March 2, 2017 2/16/2017
Omnicell (OMCL) Reports Results For Fiscal Year And Fourth Quarter 2016 2/16/2017
Semler Scientific To Report Fourth Quarter And Full Year 2016 Financial Results And Host Conference Call On March 10, 2017 2/16/2017
ANI Pharma Schedules Conference Call For Fourth Quarter And Full Year 2016 Financial Results And 2017 Guidance 2/16/2017
NxStage Medical, Inc. (NXTM) Announces First Quarter 2017 Investor Conference Schedule 2/16/2017
Shire (SHPG) Reports Full Year 2016 Results With Record Revenue; Positioned For Continued Strong Growth Driven By Best-In-Class Rare Disease Pipeline 2/16/2017
Anika Therapeutics (ANIK) Reports Fourth Quarter And Full Year 2016 Financial Results 2/16/2017
Gerresheimer Delivers Sustained Profitability Growth In 2016 And Proposes A Dividend Increase Of 23.5% 2/16/2017
Alkermes (ALKS) Reports Financial Results For The Year Ended Dec. 31, 2016 And Provides Financial Expectations For 2017 2/15/2017
BioInvent (BOVNF) Financial Statement 1 January – 31 December 2016 2/15/2017
Sarepta (SRPT) To Announce Fourth Quarter And Full-Year 2016 Financial Results And Recent Corporate Developments On February 28, 2017 2/15/2017
Spring Bank Pharmaceuticals, Inc. Provides Corporate Update And Reports 2016 Financial And Operational Results 2/15/2017
Neurocrine Biosciences (NBIX) Reports Year-End 2016 Results And Provides Investor Update For 2017 2/15/2017
China Biologic Products To Report Fourth Quarter And Fiscal Year 2016 Financial Results 2/15/2017
Jazz Pharma (JAZZ) To Report 2016 Fourth Quarter And Full Year Financial Results On February 28, 2017 2/15/2017
Genomic Health (GHDX) Announces 2016 Fourth Quarter And Year-End Financial Results, Provides 2017 Financial Outlook 2/15/2017
Axovant (AXON) Announces Dementia Pipeline Updates And Reports Financial Results For The Third Fiscal Quarter And Nine Months Ended December 31, 2016 2/15/2017
Biocryst (BCRX) To Announce Fourth Quarter And Year End 2016 Financial Results February 27 2/15/2017
ScinoPharm Reports Financial Performance For 2016 2/15/2017
Alcobra (ADHD) Announces Fourth-Quarter And Full-Year 2016 Financial Results And Provides Corporate Update 2/15/2017
United Therapeutics (UTHR) To Report Fourth Quarter And Annual 2016 Financial Results Before The Market Opens On Wednesday, February 22, 2017 2/15/2017
Compugen Ltd. (CGEN) Reports Fourth Quarter And Calendar Year 2016 Results 2/15/2017
Tesaro (TSRO) To Announce Fourth-Quarter 2016 Financial Results On February 28, 2017 2/15/2017
Ionis Pharma (IONS) To Hold 2016 Financial Results Conference Call 2/15/2017
Syneron Medical (ELOS) Reports Fourth Quarter 2016 Revenue Of $82.9 Million And Full Year 2016 Revenue $298.1 Million 2/15/2017
AMRI (AMRI) Schedules Fourth Quarter And Full Year 2016 Earnings Release And Conference Call 2/15/2017
WaferGen Biosystems Reports Revenue Growth In Fourth Quarter Of 2016 2/15/2017
Theravance (THRX) To Report Fourth Quarter And Full Year 2016 Financial Results On February 27, 2017 2/15/2017
Guerbet (GBT): 2016 Revenue 2/15/2017
QuintilesIMS (Q) Reports Fourth-Quarter And Full-Year 2016 Results, Issues First-Quarter And Full-Year 2017 Guidance 2/14/2017
Charles River  (CRL) Announces Fourth-Quarter And Full-Year 2016 Results From Continuing Operations And Provides 2017 Guidance 2/14/2017
Acorda (ACOR) Provides Financial And Pipeline Update For Fourth Quarter And Year End 2016 2/14/2017
Incyte (INCY) Reports 2016 Fourth-Quarter And Year-End Financial Results, Provides 2017 Financial Guidance And Updates On Key Clinical Programs 2/14/2017
BASi (BASI) Reports First Quarter Results 2/14/2017
Dynatronics Corporation (DYNT) Announces 16.6% Increase In Revenues For Fiscal 2017 Second Quarter 2/14/2017
Invitae Reports Revenue Of $9.2 Million In Fourth Quarter 2016 And Projects Strong Volume And Revenue Growth In 2017 2/14/2017
Bruker Corporation Reports Fourth Quarter And Fiscal Year 2016 Financial Results 2/14/2017
Merus (MRUS) Reports Fiscal Q1 2017 Results 2/14/2017
Perrigo (PRGO) To Release Fourth Quarter And Calendar Year 2016 Results On February 27, 2017 2/14/2017
TraceLink, Inc. Reports Record Year-Over-Year New Sales Bookings And 97% Growth In New Customers For 2016 2/14/2017
Penumbra Schedules Fourth Quarter And Full Year 2016 Earnings Release And Conference Call For February 28, 2017 At 5:00 PM Eastern Time 2/14/2017
Avadel Pharma (FLML) To Report Fourth Quarter And Full Year 2016 Results 2/14/2017
AMAG (AMAG) Reports Fourth Quarter And Full Year 2016 Financial Results 2/14/2017
Adocia Announces Its Revenue And Cash Position For 2016 2/14/2017
Supernus (SUPN) To Host Fourth Quarter And Full Year 2016 Earnings Conference Call 2/14/2017
Celldex (CLDX) Announces Upcoming Investor Presentations And 2016 Year-End Call 2/14/2017
Carmat (ALCAR.PA) Release: 2016 Annual Results 2/14/2017
Teva (TEVA) Reports Full Year And Fourth Quarter 2016 Financial Results 2/13/2017
Aethlon Medical (AEMD) Announces Fiscal 2017 Third Quarter Results 2/13/2017
Endo International (ENDP) To Announce Fourth-Quarter And Full-Year 2016 Financial Results 2/13/2017
SQI Diagnostics To Announce First Quarter 2017 Results 2/13/2017
DelMar Pharma Announces Second Quarter Fiscal Year 2017 Financial Results 2/13/2017
ESSA Pharma Provides Business Update And Announces Financial Results For The First Quarter Ended December 31, 2016 2/13/2017
Ohr Pharma (OHRP) To Announce First Quarter 2017 Financial Results On February 14 2/13/2017
Clovis Oncology (CLVS) To Announce Fourth Quarter/Year-End 2016 Financial Results And Host Webcast Conference Call On February 22 2/10/2017
CEL-SCI (CVM) Corporation Reports First Quarter Fiscal 2017 Financial Results 2/10/2017
Seattle Genetics (SGEN) Reports Fourth Quarter And Year 2016 Financial Results 2/10/2017
Sensient Tech Corporation Reports Results For The Quarter And Year Ended December 31, 2016 2/10/2017
Taro (TARO) Provides Results For December 31, 2016 2/10/2017
TherapeuticsMD (TXMD) To Host Fourth Quarter And Year End 2016 Financial Results Conference Call And Webcast On February 23 2/10/2017
Innoviva Reports Fourth Quarter And Full Year 2016 Financial Results 2/10/2017
FONAR Corporation (FONR) Announces Fiscal 2017 2nd Quarter And Six Months Financial Results 2/10/2017
Elite Pharma (ELI) Reports Results For Third Quarter Of Fiscal Year 2017 2/10/2017
Immune Therapeutics Strengthens Balance Sheet; Reiterates Outlook For Positive Cash Flow By Mid Year 2/10/2017
Sonoma Pharma (OCLS) Reports Financial Results For Fiscal Third Quarter 2017 2/10/2017
NuVasive (NUVA) Reports Fourth Quarter And Full Year 2016 Financial Results 2/10/2017
Dynatronics Corporation (DYNT) Schedules Conference Call To Report Financial Results For Second Fiscal Quarter 2/10/2017
Landauer (LDR) Reports Fiscal 2017 First Quarter Results -- Net Income Up 21% 2/10/2017
Nevro (NVRO) To Report Operating Results For The Fourth Quarter And Full Year 2016 2/10/2017
Misonix (MSON) Files Form 10-K Announcing Fiscal 2016 Financial Results 2/10/2017
Organovo (ONVO) Announces Fiscal Third-Quarter 2017 Results; Company Updates Full-Year Fiscal 2017 Total Revenue Outlook 2/10/2017
Aytu BioScience Provides Second Quarter Fiscal 2017 Business Update and Financial Results 2/10/2017
Applied DNA Sciences, Inc. (APDN) Reports Fiscal First Quarter 2017 Financial Results 2/10/2017
Astrotech Reports Second Quarter Of Fiscal Year 2017 Financial Results 2/10/2017
Merus (MRUS) Announces Date Of Fiscal Q1 2017 Earnings Release 2/10/2017
IntelliPharmaCeutics Announces 2016 Year End Results 2/10/2017
Enanta Pharmaceuticals, Inc. Reports Financial Results For Its Fiscal First Quarter Ended December 31, 2016 2/9/2017
Alnylam (ALNY) Reports Fourth Quarter And Full Year 2016 Financial Results And Highlights Recent Period Activity 2/9/2017
Alkermes (ALKS) To Host Conference Call To Discuss Fourth Quarter And Year-End 2016 Financial Results 2/9/2017
Medidata Solutions, Inc. Reports Record Full-Year And Fourth Quarter 2016 Results 2/9/2017
MDxHealth, Inc. (MXDHF) Notice Of Financial Year 2016 Results 2/9/2017
Charles River  (CRL) Changes Time Of Fourth-Quarter 2016 Earnings and 2017 Guidance Conference Call 2/9/2017
Agios (AGIO) To Webcast Conference Call Of Fourth Quarter And Full Year 2016 Financial Results On February 16, 2017 2/9/2017
Recordati: Preliminary 2016 Results Confirm Continued Growth Of Revenues And Profitability. New Three Year Business Plan Presented 2/9/2017
Invacare (IVC) Announces Financial Results For The Fourth Quarter And Full Year Ended December 31, 2016 2/9/2017
Unlike Many of Its Peers, Allergan (AGN) Beats Forecast and Is on the Hunt for More M&A Deals 2/9/2017
IsoRay (ISR) Announces Second Quarter Fiscal 2017 Financial Results 2/9/2017
Regeneron (REGN) Reports Fourth Quarter And Full Year 2016 Financial And Operating Results 2/9/2017
Palatin Tech (PTN) Reports Second Quarter Fiscal Year 2017 Results; Teleconference And Webcast To Be Held On February 9, 2017 2/9/2017
Array BioPharma (ARRY) Reports Financial Results For The Second Quarter Of Fiscal 2017 2/9/2017



//-->